四川美丰化工股份有限公司 证券代码：000731 证券简称：四川美丰 公告编号：2023-31 关于召开 2022 年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 为广泛听取投资者的意见和建议，提升交流效率，现就公司 2022 年度网上业绩说明会提前向投资者公开征集问题。 投资者可提前登陆"互动易"平台"云访谈"栏目 （http://irm.cninfo.com.cn）进入公司 2022 年度网上业绩说 明会页面或通过扫描下方二维码进行提问。公司将对征集到的问 题进行整理，在本次业绩说明会上对投资者普遍关注的问题进行 集中答复。 四川美丰化工股份有限公司（以下简称"公司"）已于 2023 年 4 月 25 日在巨潮资讯网（www.cninfo.com.cn）披露了《2022 年年度报告》。为了方便广大投资者进一步了解公司 2022 年度经 营情况，公司决定召开 2022 年度网上业绩说明会。 一、本次业绩说明会安排 （一）召开时间：2023 年5 月12 日（星期五）15:00～17:00 （二）召开方式：网络互动 （三）出席人员：董 ...

Financial Performance - Sichuan Meifeng Chemical reported a profit distribution plan of 1.70 RMB per 10 shares, totaling approximately 99.8 million RMB based on 585,723,752 shares[5]. - The company's operating revenue for 2022 was ¥4,909,704,177.49, representing a 20.01% increase compared to ¥4,090,955,814.76 in 2021[6]. - The net profit attributable to shareholders for 2022 was ¥622,075,652.81, a 9.34% increase from ¥568,946,438.35 in 2021[6]. - The net cash flow from operating activities increased by 49.07% to ¥1,009,742,050.56 in 2022, up from ¥677,381,415.59 in 2021[6]. - The basic earnings per share for 2022 was ¥1.0621, reflecting a 10.15% increase from ¥0.9642 in 2021[6]. - Total assets at the end of 2022 reached ¥5,173,941,582.64, a 17.27% increase from ¥4,411,814,359.51 at the end of 2021[6]. - The net assets attributable to shareholders increased by 16.78% to ¥3,991,182,286.35 at the end of 2022, compared to ¥3,417,751,137.38 at the end of 2021[6]. - The company achieved a revenue of 4.91 billion yuan and a net profit attributable to shareholders of 622 million yuan, representing a year-on-year growth of 9.34%[86]. - The company reported a total revenue of approximately CNY 579.97 million for the year 2022, reflecting a significant increase compared to the previous year[149]. - The company achieved a net profit of CNY 4.60 million, indicating a growth of 8.2% year-on-year[150]. Business Operations and Strategy - The company has not changed its main business since its listing, maintaining a focus on chemical production[22]. - Future plans and development strategies are subject to market conditions and management efforts, indicating significant uncertainty[4]. - The company aims to transform from a pure producer to a comprehensive enterprise that combines production and service, enhancing its market management mechanism[37]. - The company plans to deepen institutional reforms and integrate internal and external resources to improve product quality and sales in 2023[37]. - The company is focusing on transitioning towards green and sustainable development in the fertilizer industry, driven by increasing demand for high-efficiency fertilizer products[34]. - The company aims to maintain its market position and expand trade volume while enhancing its sales network and industry influence[49]. - The company is committed to continuous internal reform and improvement in operational quality to capitalize on the favorable market conditions in the chemical and fertilizer sectors[86]. - The company is focused on expanding its market presence by optimizing production capacity and enhancing sales channels, particularly in the compound fertilizer and urea markets[163]. Product Development and Innovation - The company is leveraging technological innovation and product upgrades to reduce comprehensive costs and enhance product competitiveness in response to market demands[34]. - In 2022, the company launched specialized fertilizers for various crops, including beans, tea, and citrus, as well as multi-peptide urea and chelated zinc potassium boron urea, contributing to product diversification[37]. - The company has developed a diverse product range, including urea and compound fertilizers, suitable for various fertilization methods[102]. - The company is actively involved in R&D for specialized compound fertilizers tailored to different crop nutrient needs[103]. - The company has developed several industry-leading production technologies, including energy optimization for large-scale ammonia/urea synthesis, which won first prize in provincial technology advancement[105]. - New product development includes a line of eco-friendly fertilizers, projected to contribute an additional 100 million RMB in revenue by the end of 2023[193]. Market Trends and Industry Insights - The fertilizer industry is experiencing a steady recovery in demand, supported by national environmental policies and the need for high-efficiency products to ensure food security[34]. - The car urea market is expected to grow significantly, with sales increasing from 256,000 tons in 2021 to 325,000 tons in 2022, indicating a strong upward trend[41]. - The company is adapting to the national regulatory environment, which is expected to accelerate the development of the car urea market due to stricter emission standards[41]. - The company has reported a stable operation of its melamine production facilities, achieving historical highs in both production and quality[39]. - The company is focused on enhancing its agricultural chemical services and integrated nutrient solutions to meet the growing demand for green and efficient fertilizers[36]. Risk Management and Compliance - The company emphasizes the importance of risk factors including safety and environmental risks, product price fluctuations, cost increases, and natural gas supply imbalances[4]. - To mitigate risks, the company will strictly control safety and environmental standards and optimize production cost management to enhance efficiency[166]. - The company emphasizes safety management, with a focus on training and risk control to maintain a stable safety environment[87]. - The establishment of a dynamic risk monitoring and early warning mechanism aims to enhance operational risk management, particularly for key subsidiaries and businesses[160]. Governance and Corporate Structure - The board of directors confirmed the accuracy and completeness of the annual report, with all members present for the meeting[4]. - The company has a governance structure that complies with relevant laws and regulations, ensuring no unresolved governance issues exist[169]. - The board of directors consists of 7 members, with 3 independent directors, ensuring a majority of independent oversight[171]. - The supervisory board has 7 members, including 3 shareholder representatives and 4 employee representatives, fulfilling its supervisory duties effectively[172]. - The company maintains independence from its controlling shareholder in terms of assets, personnel, finance, and operations, ensuring autonomous decision-making[175]. - The company has established a complete independent research, supply, production, and sales system, ensuring operational independence[175]. - The company has a robust internal control management system, continuously improving its governance level[169]. Future Outlook and Goals - The company has set a performance guidance for 2023, targeting a revenue growth of 10%[149]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% increase in international sales by 2024[193]. - The company aims to enhance its image as a state-owned enterprise and promote high-quality development[200]. - The company is committed to integrating party building with business operations to foster a strong corporate culture and improve overall performance[164]. - The company has outlined a strategic goal to achieve a 5% market share in the domestic chemical industry by 2025[193].

Financial Performance - The company's operating revenue for Q1 2023 was ¥1,203,738,251.59, a decrease of 3.87% compared to ¥1,252,137,083.30 in the same period last year[3] - Net profit attributable to shareholders was ¥167,186,704.81, down 6.44% from ¥178,698,756.81 year-on-year[3] - Basic and diluted earnings per share were both ¥0.2854, reflecting a decrease of 6.46% from ¥0.3051 in the same period last year[3] - Total operating revenue for Q1 2023 was CNY 1,203,738,251.59, a decrease of 3.85% compared to CNY 1,252,137,083.30 in Q1 2022[22] - Net profit for Q1 2023 was CNY 179,730,400.70, a decline of 8.69% from CNY 196,885,236.49 in Q1 2022[23] - Earnings per share for Q1 2023 were CNY 0.2854, compared to CNY 0.3051 in the same period last year, reflecting a decrease of 6.06%[23] - The total comprehensive income for Q1 2023 was CNY 180,018,160.92, down from CNY 196,534,066.20 in Q1 2022, reflecting a decrease of 8.43%[23] Cash Flow - The net cash flow from operating activities decreased significantly by 80.04%, amounting to ¥61,267,255.97 compared to ¥306,947,952.71 in the previous year[3] - Cash flow from operating activities for Q1 2023 was CNY 61,267,255.97, significantly lower than CNY 306,947,952.71 in Q1 2022[24] - The net cash flow from investment activities was CNY 142,933,930.98, compared to a negative cash flow of CNY -205,978,938.42 in the previous year, indicating a significant improvement[25] - Total cash and cash equivalents at the end of the period reached CNY 1,237,173,118.66, up from CNY 761,326,085.95 year-over-year, reflecting a net increase of CNY 226,167,853.62[25] - Cash inflow from investment activities totaled CNY 1,109,980,507.40, compared to CNY 806,553,566.30 in the same period last year, marking an increase of approximately 37.5%[25] - Cash outflow for the acquisition of fixed assets and other long-term assets was CNY 67,046,576.42, significantly higher than CNY 12,532,504.72 in the previous year, indicating increased capital expenditure[25] - The net cash flow from financing activities was CNY 21,728,071.00, compared to CNY 1,094,529.98 in the previous year, showing a substantial increase[25] - Cash inflow from borrowings was CNY 22,613,002.99, up from CNY 3,500,000.00 in the previous year, indicating a strong reliance on debt financing[25] Assets and Liabilities - Total assets increased by 1.71% to ¥5,262,464,312.57 from ¥5,173,941,582.64 at the end of the previous year[3] - Total current assets increased to CNY 3,027,523,383.13 from CNY 2,943,751,066.74, reflecting a growth of approximately 2.0%[18] - Cash and cash equivalents rose to CNY 1,240,659,618.66, up from CNY 1,014,491,765.04, representing an increase of about 22.3%[18] - Inventory increased to CNY 460,082,823.82 from CNY 367,725,885.28, marking a growth of approximately 25.0%[18] - The total liabilities as of Q1 2023 amounted to CNY 781,541,200.88, a decrease from CNY 878,532,090.96 in the previous year[20] - Total equity attributable to shareholders of the parent company increased to CNY 4,164,104,240.84 from CNY 3,991,182,286.35, representing a growth of 4.34%[20] Research and Development - Research and development expenses increased by 132% year-on-year, amounting to an additional ¥1,660,000[7] - Research and development expenses for Q1 2023 were CNY 2,915,903.17, up from CNY 1,254,513.88 in Q1 2022, indicating an increase of 132.36%[22] Management and Operations - The company reported a significant decrease in management expenses by 33%, amounting to a reduction of ¥33,700,000 compared to the previous year[7] - The company is involved in significant projects, including the investment in a natural gas trial recovery project and a high-performance oilfield additive project[13][14] - The company has not disclosed any significant changes in shareholder relationships or major acquisitions during the reporting period[12] - The company did not conduct an audit for the first quarter report, which may affect the reliability of the financial data presented[26] - The cash flow from operating activities was not detailed in the provided data, which is critical for assessing the company's operational efficiency[25] - The company reported a significant increase in cash inflow from investments, suggesting a positive trend in investment returns[25] - The overall financial health of the company appears to be improving, as indicated by the increase in cash reserves and positive cash flow from investment activities[25]

四川美丰化工股份有限公司 投资者调研现场接待预约登记表 | --- | --- | --- | --- | --- | --- | --- | --- | |-----------------------|---------------------------------------------------------------------------------------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | 是(√) | | | | | 来访时间 | 2015年 11月20日 \| 是否接待 | | | 否( | | ) | | | 来访人工作单位 及姓名 | 融通基金管理有限公司 行业研究员 范琨 上海高毅资产管理合伙企业(有限合伙） 高级研究员 李剑飞 | | | | | | | | 来访人类型 | 1、投资者( );2、证券机构(√);3、媒体( );4、其他( ) | | | | | | | | 接待时间和地点 | 1. 时间: 2015年11月20日 2. 地点:公 ...

证券代码:000731 证券简称:四川美丰 四川美丰化工股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | --- | |-------|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------|-------| | | | | | | | | | ■特定对象调研 | □分析师会议 | | | | | □媒体采访 | □业绩说明会 | | | | 活动类别 | □新闻发布会 | □路演活动 | | | | | □现场参观 | □一对一沟通 | | | | | □其他 ( ) | | | | | 参与单位名称及 | 融通基金管理有限公司 行 ...

证券简称:四川美丰 1 证券代码:000731 四川美丰化工股份有限公司 投资者关系活动记录表 | --- | --- | --- | |---------------------|-------|--------------------------------------------------------------------------------------------------------------------------------------------| | | | | | | | ■特定对象调研 □分析师会议 | | | | □业绩说明会 □媒体采访 | | 投资者关系 活动类别 | | □新闻发布会 □路演活动 | | | | □现场参观 □一对一沟通 | | | | 口其他 ( ) | | | | 国泰君安研究所 基础化工行业研究员 周新明 | | 参与单位名称及 | | 国泰君安四川分公司 高级研究员 刘帆 | | 人员姓名 | | 国泰君安四川分公司 投行部高级经理 王冉冉 | | | | 四川美丰化工股份有限公司 证券事务代表 陆爽 | | 时 间 | | 2015 年 06 ...

四川美丰化工股份有限公司 投资者调研现场接待预约登记表 | --- | --- | --- | --- | --- | --- | |-----------------------|--------------------------------------------------------------------------------------------------------------------------------------------|----------|-------|-----------|-------| | | | | | | | | | | | | 是（ √ ） | | | 来访人工作单位 及姓名 | 2015年 06月 03 日 国泰君安研究所 基础化工行业研究员 周新明 国泰君安四川分公司 高级研究员 刘帆 国泰君安四川分公司 投行部高级经理 王冉冉 | 是否接待 | | 否（ | ） | | 来访人类型 | 1、投资者( ); 2、证券机构(√); 3、媒体( ); 4、其他( ) | | | | | | 接待时间和地点 | 1. 时间: 2015 年 06 月 03 ...

四川美丰化工股份有限公司 投资者调研现场接待预约登记表 | --- | --- | --- | --- | --- | --- | --- | --- | |-----------------------|---------------------------------------------------|----------|------------------------------------------|-------|-------------|-------|-------| | | | | | | | | | | | | | | | | | | | 来访时间 | 2016年6月7日 | 是否接待 | | | 是(√) 否( ) | | | | 来访人 | | | | | | | | | 来访人姓名及工作 单位 | | | 银华基金管理有限公司 研究部研究员 胡银玉 | | | | | | 来访人类型 | 1、投资者( );2、证券机构(√);3、媒体( );4、其他( ) | | | | | | | | 接待时间和地点 | 1.时间:2016年6月7日 2.地点:公司总部会议室 | | | | ...